Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Washington University School of Medicine
Fred Hutchinson Cancer Center
Baptist Health South Florida
Institute of Hematology & Blood Diseases Hospital, China
Children's Oncology Group
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Nantes University Hospital
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Institut Curie
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
International Extranodal Lymphoma Study Group (IELSG)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Stanford University
Sun Yat-sen University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
University of Pittsburgh
Sheba Medical Center
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
Baptist Health South Florida
Memorial Sloan Kettering Cancer Center
University Hospital Tuebingen
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Masonic Cancer Center, University of Minnesota
Gruppo Italiano Trapianto di Midollo Osseo
NYU Langone Health
Nohla Therapeutics, Inc.
Lund University Hospital
Fred Hutchinson Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris